In Fig. 5B, the densitometric analysis of p-EGFR/t-EGFR levels showed a significant increase in the BPH group, which was markedly reduced following treatment with HCQ or FIN, with the combination treatment leading to the most significant reduction (p < 0.0001). The gene discussed is EGFR; the disease is benign prostatic hyperplasia.